The combination effects of acetaminophen and N-acetylcysteine on cytokines production and NF-κB activation of lipopolysaccharide-challenged piglet mononuclear phagocytes in vitro and in vivo

Veterinary Immunology and Immunopathology

Volumn 152, Issue 3-4, 2013, Pages 381-388

  Qiu, Yinsheng ^a   Zhang, Jiawei ^a   Liu, Yu ^a   Ma, Hongwei ^a   Cao, Fangyuan ^a   Xu, Jun ^a   Hou, Yongqing ^a   Xu, LingYun ^a  

^a WUHAN POLYTECHNIC UNIVERSITY   (China)

Author keywords

Acetaminophen; Cytokines; Mononuclear phagocytes; N acetylcysteine; NF B; Piglets

Indexed keywords

ACETYLCYSTEINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PARACETAMOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MONONUCLEAR PHAGOCYTE; NONHUMAN; PIGLET; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; STATISTICAL SIGNIFICANCE;

ACETAMINOPHEN; ACETYLCYSTEINE; ANIMALS; CYTOKINES; DRUG SYNERGISM; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; SUS SCROFA; TRANSCRIPTION FACTOR RELA;

EID: 84875536900     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2013.01.013     Document Type: Article

References (29)

1. Ancha H.R., Kurella R.R., Mckimmey C.C., Lightfoot S., Harty R.F. Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats. Dig. Dis. Sci. 2009, 54:758-766.
2. Blackwell T.S., Blackwell T.R., Holden E.P., Christman B.W., Christman J.W. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J. Immunol. 1996, 157:1630-1637.
3. Chanteux H., Guisset A.C., Pilette C., Sibille Y. LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respir. Res. 2007, 8:71.
4. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. 2006, 103:2274-2279.
5. Chung E.Y., Kim S.J., Ma X.J. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res. 2006, 16:154-161.
6. Cu A., Ye Q., Sarria R., Nakamura S., Guzman J., Costabel U. N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro. Sarcoidosis Vasc. Diffuse. Lung Dis. 2009, 26:147-154.
7. Dehus O., Bunk S., von Aulock S., Hermann C. IL-10 release requires stronger toll-like receptor 4-triggering than TNF: a possible explanation for the selective effects of heterozygous TLR4 polymorphism Asp(299) Gly on IL-10 release. Immunobiology 2008, 213:621-627.
8. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991, 147:3815-3822.
9. Francesca M., Carla L., Marta M., Luciano A., Lucia S., Isabella C., Angelo G., Alberto M., Mario P., Claudio M. Acetaminophen down-regulates interleukin-1β-induced nuclear factor-κB nuclear translocation in a human astrocytic cell line. Neurosci. Lett. 2003, 353:79-82.
10. Glattleider L., Capdevielle N. The use of PRACETAM paracetamol premix in postweaning multisystemic wasting syndrome PMWS and postweaning diets. Pig J. 2005, 56:131-144.
11. Graham G.G., Scott K.F. Mechanism of action of paracetamol. Am. J. Ther. 2005, 12:46-55.
12. Hirata N., Yanagawa Y., Ogura H., Satoh M., Noguchi M., Matsumoto M., Togashi H., Onoé K., Iwabuchi K. The role of tumor necrosis factor-α for interleukin-10 production by murine dendritic cells. Cell Immunol. 2011, 266:165-171.
13. Hoffer E., Baum Y., Nahir A.M. N-Acetylcysteine enhances the action of anti-inflammatory drugs as suppressors of prostaglandin production in monocytes. Mediators Inflamm. 2002, 11:321-323.
14. Hou Y., Wang L., Zhang W., Yang Z., Ding B., Zhu H., Liu Y., Qiu Y., Yin Y., Wu G. Protective effects of N-acetylcysteine on intestinal functions of piglets challenged with lipopolysaccharide. Amino Acids 2012, 43:1233-1242.
15. Hou Y., Wang L., Yi D., Ding B., Yang Z., Li J., Chen X., Qiu Y., Wu G. N-acetylcysteine reduces inflammation in the small intestine by regulating redox, EGF and TLR4 signaling. Amino Acids 2012, 10.1007/s00726-012-1295-x.
16. Johnson R.W. Inhibition of growth by proinflammatory cytokines: an intergrated view. J. Anim. Sci. 1997, 75:1244-1255.
17. Krakauer T., Buckley M. The potency of anti-oxidants in attenuating superantigen-iduced proinflammatory cytokines correlates with inactivation of NF-kappaB. Immunopharmacol. Immunotoxicol. 2008, 30:163-179.
18. Lauterburg B.H., Corcoran G.B., Mitchell J.R. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J. Clin. Invest. 1983, 71:980-991.
19. Lee J.J., Huang W.T., Shao D.Z., Liao J.F., Lin M.T. Blocking NF-kappaB activation may be an effective strategy in the fever therapy. Jpn. J. Physiol. 2003, 53:367-375.
20. Leon L.R., Kozak W., Rudolph K., Kluger M.J. An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. 1999, 276:81-89.
21. Li J., Quan N., Bray T.M. Supplementation of N-acetylcysteine normalizes lipopolysaccharide -induced nuclear factor kappaB activation and proinflammatory cytokine production during early rehabilitation of protein malnourished mice. J. Nutr. 2002, 132:3286-3292.
22. Liu Y.L., Huang J.J., Hou Y.Q., Zhu H.L., Zhao S.J., Ding B.Y., Yin Y.L., Yi G.F., Shi J.Y., Fan W. Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs. Br. J. Nutr. 2008, 100:552-560.
23. Liu Y.L., Shi J.X., Lu J., Meng G.Q., Zhu H.L., Hou Y.Q., Yin Y.L., Zhao S.J., Ding B.Y. Activation of peroxisome proliferator-activated receptor γ potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge. Innate Immun. 2009, 15:169-178.
24. Martins J.O., Ferracini M., Ravanelli N., Landgraf R.G., Jancar S. Insulin suppresses LPS-induced iNOS and COX-2 expression and NF-κB activation in alveolar macrophages. Cell Physiol. Biochem. 2008, 22:279-286.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
26. Palacio J.R., Markert U.R., Martínez P. Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages. Inflamm. Res. 2011, 60:695-704.
27. Platzer C., Meisel C., Vogt K., Platzer M., Volk H.D. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 1995, 7:517-523.
28. Ryu Y.S., Lee J.H., Seok J.H., Hong J.H., Lee Y.S., Lim J.H., Kim Y.M., Hur G.M. Acetainophen inhibits iNOS gene expression in RAW 264.7 macrophages: differential regulation of NF-kappaB by acetaminophen and salicylates. Biochem. Biophys. Res. Commun. 2000, 272:758-764.
29. Wrotek S., Jedrzejewski T., Potera-Kram E., Kozak W. Antipyretic activity of N-acetylcysteine. J. Physiol. Pharmacol. 2011, 62:669-675.